These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 9284793

  • 1. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Uthayakumar S, Birthistle K, Dalton R, Hay PE.
    Lancet; 1997 Aug 23; 350(9077):588-9; author reply 590. PubMed ID: 9284793
    [No Abstract] [Full Text] [Related]

  • 2. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Mitchell SM, Youle MS, Membrey WL, Jones CD.
    Lancet; 1997 Aug 23; 350(9077):588; author reply 590. PubMed ID: 9284792
    [No Abstract] [Full Text] [Related]

  • 3. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stein DS.
    Lancet; 1997 Aug 23; 350(9077):589-90. PubMed ID: 9284796
    [No Abstract] [Full Text] [Related]

  • 4. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Carr A, Cooper DA.
    Lancet; 1997 Aug 23; 350(9077):589; author reply 590. PubMed ID: 9284795
    [No Abstract] [Full Text] [Related]

  • 5. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stricker RB, Goldberg B.
    Lancet; 1997 Aug 23; 350(9077):589; author reply 590. PubMed ID: 9284794
    [No Abstract] [Full Text] [Related]

  • 6. Relapse of CMV retinitis in an AIDS patient with high CD4 counts.
    Petit N, Zandotti C, Riss JM, Frippiat F, Moulin JF, Gastaut JA.
    J Antimicrob Chemother; 1998 Jun 23; 41(6):666-7. PubMed ID: 9687110
    [No Abstract] [Full Text] [Related]

  • 7. Exploring the benefits and limits of highly active antiretroviral therapy.
    D'Aquila R, Walker B.
    JAMA; 1999 Nov 03; 282(17):1668-9. PubMed ID: 10553795
    [No Abstract] [Full Text] [Related]

  • 8. Discontinuing anticytomegalovirus therapy in patients with cytomegalovirus retinitis and AIDS.
    Jabs DA.
    Br J Ophthalmol; 2001 Apr 03; 85(4):381-2. PubMed ID: 11264121
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK, Karavellas MP, MacDonald JC, Plummer DJ, Freeman WR.
    Retina; 2000 Apr 03; 20(2):151-5. PubMed ID: 10783947
    [Abstract] [Full Text] [Related]

  • 10. Immune recovery vitritis in HIV infection: abstracts and commentary.
    Dunn JP.
    JAMA; 1998 Jul 08; 280(2):185-6. PubMed ID: 9669796
    [No Abstract] [Full Text] [Related]

  • 11. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV, Feinberg J, Hutchins RK, Frame RD, Schmidt DK, Viswanathan MN, Lalezari JP, McCune JM.
    J Infect Dis; 2001 Apr 15; 183(8):1285-9. PubMed ID: 11262214
    [Abstract] [Full Text] [Related]

  • 12. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
    Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR.
    J Infect Dis; 1998 May 15; 177(5):1182-7. PubMed ID: 9593001
    [Abstract] [Full Text] [Related]

  • 13. Control of cytomegalovirus retinitis after combination antiretroviral therapy.
    Ruhswurm I, Ries E, Krepler K, Derbolav A, Rieger A, Armbruster C, Wedrich A.
    Acta Ophthalmol Scand; 1999 Aug 15; 77(4):471-3. PubMed ID: 10463426
    [Abstract] [Full Text] [Related]

  • 14. Withdrawal of maintenance therapy for cytomegalovirus retinitis in AIDS patients exhibiting immunological response to HAART.
    Waib LF, Bonon SH, Salles AC, Benard G, de Oliveira AC, Pannuti CS, Pedro Rde J, Costa SC.
    Rev Inst Med Trop Sao Paulo; 2007 Aug 15; 49(4):215-9. PubMed ID: 17823749
    [Abstract] [Full Text] [Related]

  • 15. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution.
    Johnson SC, Benson CA, Johnson DW, Weinberg A.
    Clin Infect Dis; 2001 Mar 01; 32(5):815-9. PubMed ID: 11229851
    [Abstract] [Full Text] [Related]

  • 16. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Jacobson MA, Zegans M, Pavan PR, O'Donnell JJ, Sattler F, Rao N, Owens S, Pollard R.
    Lancet; 1997 May 17; 349(9063):1443-5. PubMed ID: 9164318
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.
    Walmsley SL, Raboud J, Angel JB, Mazzulli T, Shen S, Casciaro L, Young CD, Moussa G, Gough K, Rachlis A, Hopkins J.
    HIV Clin Trials; 2006 May 17; 7(1):1-9. PubMed ID: 16632459
    [Abstract] [Full Text] [Related]

  • 18. Anti-HIV drugs allow immune system to rebound, fight CMV.
    Optom Vis Sci; 2000 Jan 17; 77(1):3. PubMed ID: 10654853
    [No Abstract] [Full Text] [Related]

  • 19. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
    Tural C, Romeu J, Sirera G, Andreu D, Conejero M, Ruiz S, Jou A, Bonjoch A, Ruiz L, Arnó A, Clotet B.
    J Infect Dis; 1998 Apr 17; 177(4):1080-3. PubMed ID: 9534987
    [Abstract] [Full Text] [Related]

  • 20. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Margolis TP.
    Surv Ophthalmol; 2000 Apr 17; 44(5):455. PubMed ID: 10809654
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.